Total Chemical Synthesis of a Functionalized GFP Nanobody

被引:7
作者
Huppelschoten, Yara [1 ,2 ,3 ]
Elhebieshy, Angela F. [1 ,2 ]
Hameed, Dharjath S. [1 ,2 ]
Sapmaz, Aysegul [1 ,2 ]
Buchardt, Jens [3 ]
Nielsen, Thomas E. [3 ]
Ovaa, Huib [1 ,2 ]
van Noort, Gerbrand J. van der Heden [1 ,2 ]
机构
[1] Leiden Univ, Oncode Inst, Med Ctr, Einthovenweg 2, NL-2333 ZC Leiden, Netherlands
[2] Leiden Univ, Dept Cell & Chem Biol, Med Ctr, Einthovenweg 2, NL-2333 ZC Leiden, Netherlands
[3] Novo Nordisk, Global Res Technol, Novo Nordisk Pk, DK-2760 Malov, Denmark
关键词
chemical protein synthesis; click chemistry; nanobodies; protein modifications; solid phase peptide synthesis; LIGATION; DESULFURIZATION;
D O I
10.1002/cbic.202200304
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chemical protein synthesis has proven to be a powerful tool to access homogenously modified proteins. The chemical synthesis of nanobodies (Nb) would create possibilities to design tailored Nbs with a range of chemical modifications such as tags, linkers, reporter groups, and subsequently, Nb-drug conjugates. Herein, we describe the total chemical synthesis of a 123 amino-acid Nb against GFP. A native chemical ligation- desulfurization strategy was successfully applied for the synthesis of this GFP Nb, modified with a propargyl (PA) moiety for on-demand functionalization. Biophysical characterization indicated that the synthetic GFP Nb-PA was correctly folded after internal disulfide bond formation. The synthetic Nb-PA was functionalized with a biotin or a sulfo-cyanine5 dye by copper(I)-catalyzed azide-alkyne cycloaddition (CuAAC), resulting in two distinct probes used for functional in vitro validation in pull-down and confocal microscopy settings.
引用
收藏
页数:6
相关论文
共 34 条
  • [1] Immunogenicity Risk Profile of Nanobodies
    Ackaert, Chloe
    Smiejkowska, Natalia
    Xavier, Catarina
    Sterckx, Yann G. J.
    Denies, Sofie
    Stijlemans, Benoit
    Elkrim, Yvon
    Devoogdt, Nick
    Caveliers, Vicky
    Lahoutte, Tony
    Muyldermans, Serge
    Breckpot, Karine
    Keyaerts, Marleen
    [J]. FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [2] [Anonymous], 2020, Angew. Chem, V132, P22646
  • [3] [Anonymous], 2016, ANGEW CHEM-GER EDIT, V128, P8240
  • [4] Nanobody: a promising toolkit for molecular imaging and disease therapy
    Bao, Guangfa
    Tang, Ming
    Zhao, Jun
    Zhu, Xiaohua
    [J]. EJNMMI RESEARCH, 2021, 11 (01)
  • [5] Therapeutic Peptides Targeting PPI in Clinical Development: Overview, Mechanism of Action and Perspectives
    Cabri, Walter
    Cantelmi, Paolo
    Corbisiero, Dario
    Fantoni, Tommaso
    Ferrazzano, Lucia
    Martelli, Giulia
    Mattellone, Alexia
    Tolomelli, Alessandra
    [J]. FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 8
  • [6] Exploring cellular biochemistry with nanobodies
    Cheloha, Ross W.
    Harmand, Thibault J.
    Wijne, Charlotte
    Schwartz, Thomas U.
    Ploegh, Hidde L.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2020, 295 (45) : 15307 - 15327
  • [7] SYNTHESIS OF PROTEINS BY NATIVE CHEMICAL LIGATION
    DAWSON, PE
    MUIR, TW
    CLARKLEWIS, I
    KENT, SBH
    [J]. SCIENCE, 1994, 266 (5186) : 776 - 779
  • [8] Enhanced protein thermostability by Ala→Aib replacement
    De Filippis, V
    De Antoni, F
    Frigo, M
    de Laureto, PP
    Fontana, A
    [J]. BIOCHEMISTRY, 1998, 37 (06) : 1686 - 1696
  • [9] Single-domain antibody fragments with high conformational stability
    Dumoulin, M
    Conrath, K
    Van Meirhaeghe, A
    Meersman, F
    Heremans, K
    Frenken, LGJ
    Muyldermans, S
    Wyns, L
    Matagne, A
    [J]. PROTEIN SCIENCE, 2002, 11 (03) : 500 - 515
  • [10] Fang G., 2011, ANGEW CHEM, V123, P7787, DOI [DOI 10.1002/ANGE.201100996, 10.1002/ange.201100996]